Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Prime editing guide RNA (pegRNA) 3′ polyuridylated tail is a sequence of uridine residues typically added to the 3′ end of a pegRNA during its synthesis via RNA polymerase III transcription (Anzalone et al., 2019). This tail is a consequence of the transcription termination signal in the DNA template, which consists of a string of thymines. In the context of genome engineering, this poly(U) tail is significant because it renders the pegRNA susceptible to degradation by cellular exonucleases, thereby limiting the duration and efficiency of the prime editing process (Nelson et al., 2022). To overcome this limitation, researchers often engineer the 3′ end of the pegRNA with structural motifs, such as the evopreQ1 or tevopreQ1 RNA pseudoknots, which mask or replace the poly(U) tail to enhance RNA stability (Nelson et al., 2022). These modifications prevent the recognition of the 3' end by degradation machinery, leading to significantly higher editing yields across various cell types. Understanding and modifying this tail is a crucial aspect of optimizing prime editing for therapeutic applications, particularly in the treatment of genetic disorders where high efficiency and precision are required.
The 3′ polyuridylated tail acts as a degradation signal that recruits endogenous exonucleases, leading to the rapid turnover of the pegRNA and reducing the time available for the prime editor complex to perform genome modifications (Nelson et al., 2022).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Prime editing guide RNA 3′ polyuridylated tail (pegRNA 3′ poly(U) tail).